Bristol Myers Squibb’s admilparant showed a significant lung function benefit at 60 mg twice daily in a trial for idiopathic ...

Bristol Myers reported that its late-stage ALOFT-IPF trial of the oral drug admilparant met the primary endpoint at the 60 mg ...

Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.

Pope Leo XIV recently revealed he’ll be undergoing surgery to remove a nodular lesion discovered in his lungs.

A new perspective in Intensive Care Medicine argues that ARDS is a combined lung and pulmonary circulatory disorder, and that ...

Oct 12 (Reuters) - Bristol Myers Squibb said on Monday a lower dose of its experimental drug helped slow the decline in lung ...

Pope Leo announced Sunday that he will be having surgery this week to remove a nodule from his lung. He said that the nodule ...

The reported surgery involving Pope Leo XIV for a lung nodule has drawn focus to a common scan finding. Doctors say most ...

Pope Leo is set to undergo surgery to remove a localised lung nodule detected during recent medical examinations. While most ...

Oct 12 (Reuters) - Bristol Myers Squibb said on Monday a lower dose of its experimental drug met the main goal of a ...